Furthermore, miR-124-3p plays a protective role by inhibiting abnormal hyperphosphorylation of tau protein, a pathological event occurs in the early stage of AD, via regulating Caveolon1-PI3K/AKT/GSK-3β [35] (Figure 2). This evidence concerns the gene AKT1 and Alzheimer disease.